KAS
AUPH icon

Kemnay Advisory Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

Kemnay Advisory Services’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+945
New +$15.1K ﹤0.01% 867
2026
Q1 		– Sell
-5,150
Closed -$82.1K – 1208
2025
Q4 		$82.1K Buy
+5,150
New +$73K 0.01% 206

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kemnay Advisory Services's AUPH Position: Q2 2026 in Review

Kemnay Advisory Services opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 945 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #867 among its holdings. This is a return to the name: Kemnay Advisory Services previously reported a position in AUPH as recently as Q4 2025.

Kemnay Advisory Services first reported a position in AUPH in Q4 2025 and has held it in 2 quarters since. The position peaked at $82.1K in Q4 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Kemnay Advisory Services held 945 shares of Aurinia Pharmaceuticals worth $16K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Kemnay Advisory Services position in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #867 holding.
  • Kemnay Advisory Services first reported a position in Aurinia Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Kemnay Advisory Services's Aurinia Pharmaceuticals position peaked at $82.1K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.